Neuropace
NPCE
NPCE
22 hedge funds and large institutions have $78.6M invested in Neuropace in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
8% less funds holding
Funds holding: 24 → 22 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Holders
22
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$453K | |
| 2 | +$367K | |
| 3 | +$168K | |
| 4 |
KLC
Kent Lake Capital
Reno,
Nevada
|
+$96.7K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$37.7K |
Top Sellers
| 1 | -$1.21M | |
| 2 | -$461K | |
| 3 | -$118K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$65.2K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$33.7K |